- World rank, all time
- #42,666 of 42,892
- Rank in Moldova
- #24 of 24
- Research works
- 128 ▲ 28% vs 2013–17
- Citations
- 158 1.2 per fractional work
- Top-10% rate
- 1.1% record average 16.5%
- Open access
- 52% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.
- Medicine 4.0×
- Veterinary 3.9×
- Immunology and Microbiology 2.9×
- Agricultural and Biological Sciences 1.1×
- Biochemistry, Genetics and Molecular Biology 1.0×
- Health Professions 1.0×
- Dentistry 0.8×
- Economics, Econometrics and Finance 0.8×
- Environmental Science 0.4×
- Arts and Humanities 0.3×
- Social Sciences 0.2×
- Chemistry 0.1×
- Psychology 0.0×
- Computer Science 0.0×
- Physics and Astronomy 0.0×
Who are the top researchers at Institutul Oncologic din Republica Moldova?
Ranked on the composite score, I Spînu lead among researchers whose main affiliation is Institutul Oncologic din Republica Moldova.
- 1 I Spînu Moldova · #1,237,483 worldwide 0 citations · 19 works
Which keywords describe research at Institutul Oncologic din Republica Moldova?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Rituximab, Prognostic Factors, Chemotherapy, Epidemiology, Classification, Gene Expression Profiling, Molecular Profiling and Lymphoma.
- Cytoreductive Surgery
- Cancer Survivorship
- Genomic Analysis
- Complications
- Childhood Cancer
- Acute Lymphoblastic Leukemia
- Clinical Characteristics
- Tumor Microenvironment
- Biomarkers
- Metastasis
- Grapevine
- Myelofibrosis
- Inflammation
- Genetic Pathogenesis
- Genetics
- Prognostic Scoring System
- Lymphoma
- Gene Expression Profiling
- Chemotherapy
- Prognostic Factors
- Epidemiology
- Rituximab
- Classification
- Molecular Profiling
- PET Imaging
- Climate Change
- Cancer
- Hodgkin's Lymphoma
- JAK2 Mutation
- BCR-ABL
- Imatinib
- Mutation
- Anthocyanins
- Wine Quality
- Clinical Trials
- Cancer Incidence
- Chronic Lymphocytic Leukemia
- Genomic Aberrations
- Minimal Residual Disease
- Surgery
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology5▲ 2.9×22 topics
- Prognostic Factors4▲ 19×6 topics
- Rituximab4▲ 56×3 topics
- Chemotherapy3▲ 10×11 topics
- Classification3▲ 15×2 topics
- Gene Expression Profiling2▲ 73×2 topics
- Molecular Profiling2▲ 60×2 topics
- Lymphoma2▲ 35×2 topics
- PET Imaging2▲ 32×2 topics
- Prognostic Scoring System2▲ 141×2 topics
- Climate Change2▲ 1.93×3 topics
- Genetics2▲ 7.5×3 topics
- Cancer2▲ 3.8×9 topics
- Genetic Pathogenesis2▲ 96×1 topic
- Hodgkin's Lymphoma2▲ 96×1 topic
- Inflammation2▲ 2.3×8 topics
- JAK2 Mutation2▲ 208×1 topic
- Myelofibrosis2▲ 208×1 topic
- BCR-ABL2▲ 148×1 topic
- Grapevine2▲ 100×2 topics
- Imatinib2▲ 148×1 topic
- Metastasis2▲ 12×4 topics
- Mutation2▲ 22×3 topics
- Biomarkers2▲ 5.7×4 topics
- Anthocyanins2▲ 53×1 topic
- Tumor Microenvironment2▲ 8.1×3 topics
- Wine Quality2▲ 103×1 topic
- Clinical Characteristics1▲ 26×2 topics
- Clinical Trials1▲ 5.0×3 topics
- Acute Lymphoblastic Leukemia1▲ 96×1 topic
- Cancer Incidence1▲ 22×3 topics
- Childhood Cancer1▲ 96×1 topic
- Chronic Lymphocytic Leukemia1▲ 70×1 topic
- Complications1▲ 6.2×4 topics
- Genomic Aberrations1▲ 70×1 topic
- Genomic Analysis1▲ 12×2 topics
- Minimal Residual Disease1▲ 47×2 topics
- Cancer Survivorship1▲ 38×2 topics
- Surgery1▲ 8.0×4 topics
- Cytoreductive Surgery1▲ 38×1 topic
Which research topics does Institutul Oncologic din Republica Moldova publish most on?
By volume in 2022–2025: Lymphoma Diagnosis and Treatment, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments and Horticultural and Viticultural Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
- 2 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 2 works
- 3 Chronic Myeloid Leukemia Treatments Hematology 2 works
- 4 Horticultural and Viticultural Research Plant Science 2 works
- 5 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 6 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 1 works
- 7 Zoonotic diseases and public health Public Health, Environmental and Occupational Health 1 works
- 8 Ovarian cancer diagnosis and treatment Reproductive Medicine 1 works
- 9 Multiple and Secondary Primary Cancers Epidemiology 1 works
- 10 Cancer Immunotherapy and Biomarkers Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institutul Oncologic din Republica Moldova's research output changed?
Output in 2018–2022 was 28% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Chisinau
- Moldova State University
- Academy of Sciences of Moldova
- Nicolae Testemițanu State University of Medicine and Pharmacy
- Technical University of Moldova
- Institute of Applied Physics
- Academy of Economic Studies of Moldova
- State University of Physical Education and Sport
- Institute of Mathematics and Computer Science
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.